Respiratory Muscle Strength as a Discriminator of Sarcopenia in Community-Dwelling Elderly: A Cross-Sectional Study
- 27 Downloads
To compare the values obtained from maximum respiratory pressures (MRP) between sarcopenic and non-sarcopenic elderly; to verify the association of maximum respiratory pressures with sarcopenia and its indicators; and to establish cut-off points for MRP as a discriminator of sarcopenia.
Community-dwelling elderly ≥ 60 years old, both sexes.
Evaluation of respiratory muscle strength (maximal inspiratory pressure - MIP and maximal expiratory pressure - MEP) and sarcopenia, according to the European Working Group on Sarcopenia in Older People (EWGSOP), in which the diagnosis of this condition considered the reduction of muscle mass (muscle mass index - MMI) associated with muscle strength reduction (hand grip strength - HGS) and / or impairment in physical performance (gait speed - GS).
The sample consisted of 383 elderly individuals, with a mean age of 70.02 ± 7.3 years and a prevalence of sarcopenia of 12.53% (n = 48). Sarcopenic individuals presented significantly lower (obtained, obtained versus predicted) mean values for the maximal respiratory pressures compared to the non-sarcopenic elderly, and these were inversely associated with sarcopenia (an increase by 1 cmH2O in MIP and MEP reduced by 5% and 3%, respectively, the probability of sarcopenia). In relation to the association with the sarcopenia indicators, the increase by 1 cmH2O in MIP and MEP decreased, respectively, the probability of decreasing muscle strength (3% and 2%), GS (3% and 4%) and MMI (3 % - MIP). Cut-off points ≤60 cmH2O and ≤50 cmH2O for MEP and ≤55 cmH2O and ≤45 cmH2O for MEP, respectively for elderly men and women, served as a discriminant criterion for the presence of sarcopenia (area under the ROC curve superior to 0.70).
Elderly patients with sarcopenia had lower MIP and MEP values when compared to non-sarcopenic individuals, and respiratory muscle strength was inversely associated with the diagnosis of sarcopenia and its indicators (HGS, gait speed and MMI). Furthermore, cut-off points for MIP and MEP can be used in clinical practice as discriminators of sarcopenia in community-dwelling elderly.
Key wordsSarcopenia muscle strength respiratory muscles respiratory function tests aged
- 2.Moraes EM. Atenção à saúde do idoso: aspectos conceituais. Brasil, 2012.Google Scholar
- 3.United Nations Organization. World population prospects: the 2017 revision, key findings and advance tables. Available: https://esa.un.org/unpd/wpp/. Accessed 02 december 2017.
- 4.Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39:412–23. doi: 10.1093/ageing/afq034.Google Scholar
- 8.Instituto Brasileiro de Geografia e Estatística, 2010. Cidades. Macapá. Available: http://www.cidades.ibge.gov.br. Accessed 13 december 2017.
- 9.Instituto Brasileiro de Geografia e Estatística, 2010. Síntese de Indicadores Sociais: uma análise das condições de vida da população brasileira. Brasil.Google Scholar
- 13.Green M, Road J, Sieck GC, Similowski T. Tests of respiratory muscle strenght. Am J Respir Crit Care Med. 2002; 166:528–47.Google Scholar
- 19.Delmonico MJ, Harris TB, Lee JS, Visser M, Nevitt M, Kritchevsky SB et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc. 2007;55:769–774. doi: 10.1111/j.1532-5415.2007.01140.xCrossRefPubMedGoogle Scholar
- 21.American Society of Hand Therapists. Clinical assessment recommendations. Chicago; 1992.Google Scholar
- 23.Nakano MM (2007) Versão Brasileira da Short Physical Performance Battery -SPPB: Adaptação Cultural e Estudo da Confiabilidade. University State of Campinas.Google Scholar
- 26.Benedetti TRB, Mazo GZ, Barros MVG. Application of the International Physical Activity Questionnaire (IPAQ) for evaluation of elderly women: concurrent validity and test-retest reprodutibility. Rev. bras. ciênc. mov. 2004;12(1):25–33.Google Scholar